ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$21.69
+3.58%
Mkt Cap $3.66B
Analyst Ratings
Buy
10
Hold
1
Sell
0
Price Target (60 analysts)
$34.78
Range $29.00 – $40.00
Implied Upside
+60.4%
Consensus $34.78 vs current $21.69
NASDAQ·Healthcare·Biotechnology
$21.69
+3.58%
Mkt Cap $3.66B
Buy
10
Hold
1
Sell
0
Price Target (60 analysts)
$34.78
Range $29.00 – $40.00
+60.4%
Consensus $34.78 vs current $21.69